As of 12:31 PM on the 29th, Celltrion is trading at 316,500 KRW, up 1.28% from the previous day. This marks a 40.98% increase compared to June 2. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a net purchase of 35,715 shares of Celltrion, while institutions have a net sale of 27,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 57,861 shares, foreigners have net purchased 193,902 shares, and institutions have net sold 272,086 shares.

On June 23, Celltrion was a market topic with the headline "'Remsima' shows improvement effects on COVID-19, leading to a strong performance."



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing